Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hsiri Therapeutics

Hsiri Therapeutics?uq=kzBhZRuG
2012 FOUNDED
PRIVATE STATUS
Seed LATEST DEAL TYPE
$70K LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of infectious diseases antibiotics designed to cure mycobacterial diseases. The company's antibiotics utilize the bacteria's own iron capture molecules and couple them to conventional antibacterial compounds which target the antibiotics to the bacteria and can avoid a number of bacterial resistance mechanisms, enabling patients to resist various bacterial diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 1400 North Providence Road, Building 1
  • Suite 115S
  • Media, PA 19063
  • United States

+1 (484) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hsiri Therapeutics’s full profile, request a free trial.

Hsiri Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 17-Dec-2015 $70K 00000 Completed Startup
1. Seed Round 11-Jun-2015 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Hsiri Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioAdvance Venture Capital Minority 000 0000 000000 0

Hsiri Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Marvin Miller Chief Scientific Officer
William Claypool MD Co-Founder, President & Chief Executive Officer
Ivan Joseph Chief Financial Officer
Dennis Willson Co-Founder & Chairman

Hsiri Therapeutics Board Members (1)

Name Representing Role Since Contact
Info
Dennis Willson Self Co-Founder & Chairman 000 0000